Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,766 | 327 | 81.0% |
| Travel and Lodging | $1,156 | 4 | 9.6% |
| Education | $1,115 | 25 | 9.2% |
| Gift | $16.78 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| COLOPLAST CORP | $1,482 | 71 | $0 (2024) |
| ABBVIE INC. | $1,017 | 39 | $0 (2024) |
| Boston Scientific Corporation | $997.98 | 14 | $0 (2020) |
| EDAP TECHNOMED INC | $742.00 | 5 | $0 (2023) |
| Allergan, Inc. | $737.36 | 11 | $0 (2022) |
| Astellas Pharma US Inc | $667.32 | 20 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $641.46 | 36 | $0 (2024) |
| BIOTISSUE HOLDINGS, INC. | $513.67 | 7 | $0 (2023) |
| NeoTract Inc. | $414.45 | 2 | $0 (2020) |
| PROGENICS PHARMACEUTICALS, INC. | $329.69 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,391 | 46 | HISTOSONICS,INC. ($272.40) |
| 2023 | $2,321 | 59 | BIOTISSUE HOLDINGS, INC. ($513.67) |
| 2022 | $1,823 | 61 | EDAP TECHNOMED INC ($259.00) |
| 2021 | $1,520 | 79 | COLOPLAST CORP ($389.67) |
| 2020 | $1,461 | 39 | NeoTract Inc. ($414.45) |
| 2019 | $940.77 | 29 | Allergan Inc. ($177.58) |
| 2018 | $1,724 | 23 | Boston Scientific Corporation ($655.24) |
| 2017 | $872.55 | 21 | MERZ NORTH AMERICA, INC. ($202.46) |
All Payment Transactions
357 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/12/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 11/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.31 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/17/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: UROLOGY | ||||||
| 10/08/2024 | HISTOSONICS,INC. | — | Food and Beverage | Cash or cash equivalent | $272.40 | General |
| 10/05/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Immunotherapy | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Oncology | ||||||
| 09/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.37 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/12/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 08/23/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $31.98 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/23/2024 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: Genetic Disease | ||||||
| 08/15/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $29.69 | General |
| Category: Oncology | ||||||
| 08/09/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: ONCOLOGY | ||||||
| 08/06/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 07/24/2024 | Becton, Dickinson and Company | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: Urology | ||||||
| 07/18/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $28.01 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 06/21/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: UROLOGY | ||||||
| 06/01/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: ONCOLOGY | ||||||
| 05/31/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: ONCOLOGY | ||||||
| 05/30/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $20.98 | General |
| 05/17/2024 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: ONCOLOGY | ||||||
| 05/15/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $29.63 | General |
| 05/14/2024 | CONMED Corporation | CONMED SPECIMEN RETRIEVAL (Device) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: GENERAL SURGERY | ||||||
| 05/08/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,356 | 1,921 | $484,497 | $180,711 |
| 2022 | 16 | 1,824 | 2,600 | $527,804 | $208,802 |
| 2021 | 20 | 1,691 | 2,413 | $535,406 | $205,636 |
| 2020 | 19 | 1,920 | 2,839 | $554,915 | $193,812 |
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 371 | 665 | $90,241 | $48,233 | 53.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 199 | 199 | $53,391 | $26,530 | 49.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 176 | 213 | $36,000 | $21,986 | 61.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 78 | 99 | $45,700 | $21,279 | 46.6% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 15 | 105 | $68,160 | $14,158 | 20.8% |
| 0421T | Waterjet destruction of prostrate accessed through the urethra | Facility | 2023 | 15 | 15 | $30,000 | $9,293 | 31.0% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 14 | 14 | $32,600 | $8,523 | 26.1% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2023 | 13 | 13 | $44,250 | $7,067 | 16.0% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 29 | 30 | $13,625 | $5,927 | 43.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 29 | 29 | $9,610 | $5,489 | 57.1% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 38 | 40 | $15,650 | $4,960 | 31.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 23 | $5,361 | $3,439 | 64.1% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 68 | 119 | $17,995 | $1,286 | 7.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 91 | 109 | $12,925 | $1,049 | 8.1% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 15 | 33 | $3,614 | $1,019 | 28.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 182 | 215 | $5,375 | $473.00 | 8.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 374 | 638 | $84,140 | $47,863 | 56.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 227 | 278 | $42,215 | $28,233 | 66.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 101 | 120 | $51,000 | $26,106 | 51.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 174 | 174 | $45,240 | $23,479 | 51.9% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2022 | 29 | 29 | $91,800 | $21,701 | 23.6% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2022 | 27 | 27 | $59,400 | $16,660 | 28.0% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 18 | 95 | $73,150 | $13,396 | 18.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 48 | 48 | $15,600 | $8,825 | 56.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 38 | 44 | $10,120 | $6,818 | 67.4% |
About David Laub
David Laub is a Urology healthcare provider based in Santa Barbara, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982652780.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Laub has received a total of $12,053 in payments from pharmaceutical and medical device companies, with $1,391 received in 2024. These payments were reported across 357 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($9,766).
As a Medicare-enrolled provider, Laub has provided services to 6,791 Medicare beneficiaries, totaling 9,773 services with total Medicare billing of $788,961. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Santa Barbara, CA
- Active Since 05/04/2006
- Last Updated 12/12/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1982652780
Products in Payments
- AMS (Device) $771.62
- TITAN (Device) $580.00
- XTANDI (Drug) $551.47
- NEOX (Medical Supply) $513.67
- BOTOX (Biological) $484.78
- AVEED (Biological) $451.83
- UroLift (Device) $414.45
- ORGOVYX (Drug) $368.47
- LUPRON DEPOT (Drug) $362.12
- PYLARIFY (Drug) $329.69
- SpeediCath (Device) $322.05
- ERLEADA (Drug) $282.97
- Myrbetriq (Drug) $248.02
- AquaBeam Robotic System (Device) $247.18
- Natesto (Drug) $225.78
- XIAFLEX (Biological) $215.91
- SPEEDICATH (Device) $210.44
- Xeomin (Biological) $202.46
- iTIND System (Device) $161.72
- Titan (Device) $156.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Santa Barbara
Steven Mills, M.d, M.D
Urology — Payments: $53,066
Daniel Curhan, M.d, M.D
Urology — Payments: $30,495
Dr. Pierre-Alain Hueber, Md, Phd, MD, PHD
Urology — Payments: $12,930
Julie Chacko, Md, MD
Urology — Payments: $12,750
Scott Tobis, M.d, M.D
Urology — Payments: $7,961
Alex Koper, M.d, M.D
Urology — Payments: $4,689